Discovery & Development

Will the antibiotic apocalypse kill us all?

Will antibody drug conjugates live up to the ever-growing expectations surrounding them?

With many APIs exhibiting a strong, bitter taste, taste-masking is essential, particularly for pediatric patients.

How do we battle gut bacteria that reduce medicine efficacy?

The game “Tumor Quest” seeks to improve people’s understanding of cancer.

At the helm of SkinBioTherapeutics, Catherine O’Neill and her team are exploring the ways in which probiotic bacteria can be used topically.

When it comes to formulation, many choices should be carefully considered – and regulators expect excipient selection to be justified.

Complex formulations bring complex technical challenges.

Could blood cells provide the ideal environment to test new drugs for neuropsychiatric disorders?

PVP has a long pedigree of use in both medicinal and pharma applications – and innovations continue to emerge.